التفاصيل البيبلوغرافية
| العنوان: |
SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA. |
| المؤلفون: |
Dytfeld, Dominik, Radocha, Jakub, Hajek, Roman, Cengiz-Seval, Guldane, Berkac, Meral, Coriu, Daniel, Derman, Benjamin, Jakubowiak, Andrzej, Peceliunas, Valdas, Mikala, Gabor, Bołkun, Łukasz, Hawrylecka, Dorota, Grosicki, Sebastian, Tyczyńska, Agata, Zaucha, Jan Maciej, Knopińska, Wanda, Semeńczuk, Grażyna, Morawska, Marta, Giannopoulos, Krzysztof, Puła, Anna |
| المصدر: |
Acta Haematologica Polonica; 2023, Vol. 54 Issue 2, p82-85, 4p |
| مصطلحات موضوعية: |
SARS-CoV-2, MULTIPLE myeloma, COVID-19 |
| مستخلص: |
Introduction: Despite several studies, the impact of coronavirus disease 2019 on patients with multiple myeloma remains uncertain. Material and methods: We performed a survey that covered the period of the first and second waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in 23 centers inseven countries. Out of 352 patients with myeloma and SARS-CoV-2, 23% died. Results/Conclusions: Logistic regression showed a lower risk of death among patients treated with proteasome inhibitor and a higher risk of death for those who had a severe or a very severe course of disease. [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Haematologica Polonica is the property of VM Medica-VM Group (Via Medica) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
